Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test for Alzheimer’s Disease Assessment – Quest Diagnostics
Quest Diagnostics announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, with the goal of broadening access to quality blood tests… read more.
